Am J Transplant, Volume 19, Suppl 3 Archives - Page 57 of 214 - ATC Abstracts

2019 American Transplant Congress
Maternal and Pregnancy Outcomes after Living Donor Nephrectomy in a Multistate Cohort
G. S. Lee¹, R. X. Wang², D. O. Walls³, P. P. Reese⁴, D. S. Goldberg⁴, P. L. Abt¹
¹Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, ²Sidney Kimmel Medical College, Philadelphia, PA, ³Surgery, Rutgers Robert Wood Johnson, New Brunswick, NJ, ⁴Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: Studies have demonstrated increased risk of preeclampsia for pregnancies after kidney donation in homogenous populations or single-center studies. Our study aims to delineate maternal…
2019 American Transplant Congress
Nationwide Survey of Human T Cell Leukemia Virus Type 1-Infected Kidney Transplant Recipients in Japan
J. Yamauchi¹, Y. Yamano¹, M. Matsuoka², N. Ichimaru³, M. Nishikido⁴, Y. Shibagaki⁵, A. Sugitani⁶, N. Nakamura⁷, M. Mieno⁸, K. Yuzawa⁹
¹Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan, ²Institute for Virus Research, Kyoto University, Kyoto, Japan, ³Advanced Technology for Transplantation, Osaka University, Osaka, Japan, ⁴Blood Purification Center, Nagasaki University, Nagasaki, Japan, ⁵Department of Nephrology and Hypertention, St. Marianna University School of Medicine, Kawasaki, Japan, ⁶NHO Yonago Medical Center, Yonago, Japan, ⁷Fukuoka University, Fukuoka, Japan, ⁸Center for Information, Jichi Medical University, Shimotsuke, Japan, ⁹Department of Transplantation Surgery, National Hospital Organization Mito Medical Center, Ibaraki, Japan
*Purpose: Human T-cell leukemia virus type 1 (HTLV-1) infects 5 to 10 million people worldwide, and is endemic in Japan, sub-Saharan Africa, South America, and…
2019 American Transplant Congress
The Clinical & Economic Impact Of Allosensitization In Liver Alone And Simultaneous Liver Kidney Transplantation
M. Askar¹, G. Saracino¹, A. Elsabbagh², J. Fung³, T. Srinivas⁴, S. Flechner⁵, J. Trotter¹, G. Testa¹, B. Kaplan⁶, G. Klintmalm¹, J. Schold⁵, S. Asrani¹
¹Transplant Center, Baylor Scott & White, Dallas, TX, ²St. Vincent Health, Indianapolis, IN, ³University of Chicago Medicine, Chigao, IL, ⁴Intermountain Healthcare, Salt Lake City, UT, ⁵Cleveland Clinic, Cleveland, OH, ⁶Transplant Center, Baylor Scott & White, Temple, TX
*Purpose: Allosensitization is thought to have marginal impact among patients that undergo liver transplantation (LTA); further among simultaneous liver kidney transplantation (SLKT), livers may protect…
2019 American Transplant Congress
Rejection Of Optic And Sciatic Transplants
M. Yonar¹, M. Uehara¹, V. Kasinath¹, F. Bei², R. Abdi¹
¹Renal, Brigham and Women's Hospital, Boston, MA, ²Neurosurgery, Brigham and Women's Hospital, Boston, MA
*Purpose: Mechanisms of rejection of peripheral nerve and optic nerve remains largely unknown. The inability to prevent rejection of the optic nerve has thwarted the…
2019 American Transplant Congress
Global Kidney Exchange
D. N. Bozek¹, O. Ekwenna¹, S. Paloyo², T. Dunn³, K. Krawiec⁴, S. Rees⁵, A. Roth⁶, M. Zimmerman⁷, J. Punch⁸, R. Forbes⁹, C. Marsh¹⁰, C. Kuhr¹¹, J. Rogers¹², M. Tan¹³, L. Basagoitia¹⁴, R. Correa-Rotter¹⁵, J. Ortiz¹, P. Sindhwani¹, M. A. Rees¹
¹University of Toledo Medical Center, Toledo, OH, ²University of the Philippines – Philippine General Hospital; St. Luke’s Medical Center, Manila, Philippines, ³University of Minnesota, Minneapolis, MN, ⁴Duke University, Durham, NC, ⁵Alliance for Paired Donation, Perrysburg, OH, ⁶Stanford University, Stanford, CA, ⁷Froedert Hospital-Medical College of Wisconsin, Milwaukee, WI, ⁸University of Michigan, Ann Arbor, MI, ⁹Vanderbilt University Medical Center, Nashville, TN, ¹⁰Scripps Green Hospital, San Diego, CA, ¹¹Virginia Mason Medical Center, Seattle, WA, ¹²Wake Forest Baptist Medical Center, Winston-Salem, NC, ¹³Piedmont Hospital, Atlanta, GA, ¹⁴ProRenal, ., Mexico, ¹⁵INNSZ, Mexico City, Mexico
*Purpose: Poverty prevents more kidney transplants (KTs) worldwide than any other barrier. Global kidney Exchange (GKE) is a mechanism to overcome this barrier.*Methods: In high-income…
2019 American Transplant Congress
Tacrolimus Concentrations Can Be Reliably Measured in Capillary Microsamples
M. T. Gustavsen, N. Vethe, M. Lauritsen, A. Andersen, A. Åsberg, S. Bergan, K. Midtvedt
Oslo University Hospital, Rikshospitalet, Oslo, Norway
*Purpose: Routine therapeutic drug monitoring (TDM) of tacrolimus (Tac) is currently performed in venous bloods samples drawn at the hospital. The novel volumetric absorptive microsampling…
2019 American Transplant Congress
Pre-Transplant Cardiac Work Up Does Not Predict Post-Transplant Cardiac Events at One Year among Kidney and Pancreas Transplant Recipients
S. M. Riad¹, S. Konety¹, S. Jackson², N. Raj¹, V. Vakil¹, D. Keys¹, E. Finger³, R. Spong¹
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Death with functioning kidney allograft due to cardiovascular etiology is among the leading causes of kidney allograft loss after transplantation. Current cardiac work up…
2019 American Transplant Congress
Effect of Induction Therapy on Outcomes of De Novo Renal Transplant Recipients Receiving Everolimus with Reduced-Dose Calcineurin Inhibitor: 24-Month Results from the TRANSFORM Study
R. Oberbauer¹, F. Vincenti¹, O. Viklicky¹, U. Huynh-Do¹, D. Kim¹, J. M. Cruzado¹, Y. Qazi¹, M. S. Kim¹, P. Narvekar², M. P. Hernandez Gutierrez², P. Bernhardt², D. Kuypers¹
¹TRANSFORM Study Group, Basel, Switzerland, ²Novartis Pharma AG, Basel, Switzerland
*Purpose: To assess the effect of induction therapy on efficacy and safety outcomes of de novo renal transplant recipients (RTxR) receiving everolimus with reduced calcineurin…
2019 American Transplant Congress
Type-1 Interferons Impair the Key Immunoregulatory Activity of IL-10 in the Promotion of Transplant Tolerance
M. Iglesias Lozano, M. Chicco, D. Bibicheff, G. Brandacher, G. Raimondi
Plastic Surgery, Johns Hopkins University, Baltimore, MD
*Purpose: Induction of long term transplant survival by “costimulation blockade” (CoB) regimens is impaired by inflammatory responses. Despite the identification of type-1 interferons (TI-IFN) as…
2019 American Transplant Congress
Rapid Growth of HCV-Infected Donors for HCV-Uninfected Kidney and Liver Transplant Recipients in the United States
M. Bowring, A. Shaffer, A. Massie, N. Desai, M. Sulkowski, A. Cameron, J. Garonzik-Wang, D. Segev
Johns Hopkins University, Baltimore, MD
*Purpose: Several single-center reports of using HCV-viremic organs for HCV-uninfected recipients were recently published in the US. In light of recent DAA introduction, we sought…